Addition of a Homologous Internal Control to a Real-Time PCR Assay for Detection of Bordetella Pertussis (Technical Briefs) Addition of a Homologous Internal Control to a Real-Time PCR Assay for Detection of Bordetella Pertussis (Technical Briefs)

Addition of a Homologous Internal Control to a Real-Time PCR Assay for Detection of Bordetella Pertussis (Technical Briefs‪)‬

Clinical Chemistry 2005, Dec, 51, 12

    • €2.99
    • €2.99

Publisher Description

Pertussis, also called whooping cough, is caused by Bordetella pertussis. The disease may show an atypical course, particularly in neonates and elderly patients. A rapid and safe diagnostic method is thus essential for appropriate treatment and prophylaxis. Culture has been considered the gold standard for detection of B. pertussis, but this method often lacks sensitivity, and a minimum of 4 days may be required to obtain results (1, 2). PCR is a rapid, sensitive, and specific method for the diagnosis of pertussis (3-5). In this study, a new molecular assay was established based on real-time PCR and including a homologous internal control (IC). We evaluated the performance of this assay with a commercially available genomic DNA isolate and with clinical samples.

GENRE
Science & Nature
RELEASED
2005
1 December
LANGUAGE
EN
English
LENGTH
8
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
230.8
KB
Fully Automated, Homogeneous Nucleic Acid Detection Technology Based on Dry-Reagent Assay Chemistry and Time-Resolved Fluorometry (Abstracts of Oak Ridge Posters) Fully Automated, Homogeneous Nucleic Acid Detection Technology Based on Dry-Reagent Assay Chemistry and Time-Resolved Fluorometry (Abstracts of Oak Ridge Posters)
2007
Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs) Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs)
2006
Semiautomation of Nucleic Acid-Based Assays for Chlamydia Trachomatis and Neisseria Gonorrhoeae (Technical Briefs) Semiautomation of Nucleic Acid-Based Assays for Chlamydia Trachomatis and Neisseria Gonorrhoeae (Technical Briefs)
2001
MALDI-TOF and Tandem MS for Clinical Microbiology MALDI-TOF and Tandem MS for Clinical Microbiology
2017
Molecular Analysis and Genome Discovery Molecular Analysis and Genome Discovery
2011
Comparative Efficacy of Pcr-Based Restriction Fragment Length Polymorphism (RFLP) & Multiplex PCR for Glycoprotein B (Gb) Genotyping of Human Cytomegalovirus (Polymerase Chain Reaction) (Report) Comparative Efficacy of Pcr-Based Restriction Fragment Length Polymorphism (RFLP) & Multiplex PCR for Glycoprotein B (Gb) Genotyping of Human Cytomegalovirus (Polymerase Chain Reaction) (Report)
2007
Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report) Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs) DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs) Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial) High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs) Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial) Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial)
2003